Brokerages Set Axcelis Technologies, Inc. (NASDAQ:ACLS) Target Price at $154.00

Axcelis Technologies, Inc. (NASDAQ:ACLS) has been given a consensus recommendation of “Hold” by the seven research firms that are currently covering the stock, Marketbeat Ratings reports. Four investment analysts have rated the stock with a hold recommendation and three have issued a buy recommendation on the company. The average 12 month price target among brokers that have updated their coverage on the stock in the last year is $154.00.

A number of research firms have weighed in on ACLS. Craig Hallum reduced their price objective on shares of Axcelis Technologies from $115.00 to $105.00 and set a “buy” rating for the company in a research report on Wednesday, January 15th. Benchmark lowered shares of Axcelis Technologies from a “buy” rating to a “hold” rating in a research note on Friday, November 8th. William Blair lowered Axcelis Technologies from an “outperform” rating to a “market perform” rating in a research note on Wednesday, February 12th. Finally, Needham & Company LLC restated a “hold” rating on shares of Axcelis Technologies in a research report on Wednesday, February 12th.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of ACLS. Pacer Advisors Inc. increased its position in Axcelis Technologies by 78,037.4% during the fourth quarter. Pacer Advisors Inc. now owns 782,155 shares of the semiconductor company’s stock worth $54,649,000 after purchasing an additional 781,154 shares during the last quarter. Norges Bank purchased a new stake in Axcelis Technologies in the 4th quarter valued at about $36,050,000. Reinhart Partners LLC. boosted its position in shares of Axcelis Technologies by 50.7% during the 4th quarter. Reinhart Partners LLC. now owns 1,036,112 shares of the semiconductor company’s stock worth $72,393,000 after purchasing an additional 348,504 shares during the period. Boston Trust Walden Corp increased its holdings in Axcelis Technologies by 61.9% in the 4th quarter. Boston Trust Walden Corp now owns 820,116 shares of the semiconductor company’s stock valued at $57,302,000 after purchasing an additional 313,689 shares during the last quarter. Finally, American Century Companies Inc. raised its position in Axcelis Technologies by 37.8% in the fourth quarter. American Century Companies Inc. now owns 1,060,096 shares of the semiconductor company’s stock valued at $74,069,000 after purchasing an additional 290,678 shares during the period. Hedge funds and other institutional investors own 89.98% of the company’s stock.

Axcelis Technologies Stock Up 0.1 %

ACLS stock opened at $54.87 on Friday. Axcelis Technologies has a one year low of $53.67 and a one year high of $158.61. The company has a debt-to-equity ratio of 0.04, a quick ratio of 4.05 and a current ratio of 5.41. The firm’s fifty day moving average is $67.21 and its 200 day moving average is $82.83. The firm has a market cap of $1.78 billion, a PE ratio of 8.92, a P/E/G ratio of 4.52 and a beta of 1.52.

Axcelis Technologies (NASDAQ:ACLS) last issued its quarterly earnings data on Monday, February 10th. The semiconductor company reported $1.54 EPS for the quarter, beating the consensus estimate of $1.25 by $0.29. Axcelis Technologies had a return on equity of 21.02% and a net margin of 19.75%. On average, research analysts forecast that Axcelis Technologies will post 2.55 EPS for the current year.

About Axcelis Technologies

Axcelis Technologies, Inc designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips in the United States, Europe, and Asia Pacific. The company offers high energy, high current, and medium current implanters for various application requirements.